Chamomile Completed Phase 2 Trials for Radiodermatitis

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT02249884Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis